18:09 , Jun 1, 2018 |  BC Week In Review  |  Financial News

JHL raises $106M in bond deal

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million on May 15 in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were new investor Ruihua...
16:45 , May 30, 2018 |  BC Extra  |  Financial News

JHL raises $106M in bond deal

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were Ruihua Investment, existing investor Milestone Capital...
17:20 , Dec 16, 2016 |  BC Week In Review  |  Company News

JHL, Sanofi deal

JHL granted Sanofi exclusive, Chinese development and commercialization rights to biosimilar rituximab (JHL1101). JHL will receive $21 million up front and is eligible for up to $236 million in milestones, plus royalties. Sanofi also invested...
21:46 , Dec 5, 2016 |  BC Extra  |  Company News

Sanofi invests in JHL, gets biosimilar rights

JHL Biotech Inc. (TPex-E:6540) granted Sanofi (Euronext:SAN: NYSE:SNY) rights in China to develop and commercialize biosimilar rituximab ( JHL1101 ), as well as options for rights to other JHL candidates. JHL is to receive $21...